Skip to main content

Ticagrelor in patients with acute coronary syndromes and stroke: interpretation of subgroups in clinical trials.

Publication ,  Journal Article
James, SK; Pieper, KS; Cannon, CP; Storey, RF; Becker, RC; Steg, PG; Wallentin, L; Harrington, RA; PLATO study group,
Published in: Stroke
May 2013

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Stroke

DOI

EISSN

1524-4628

ISSN

0039-2499

Publication Date

May 2013

Volume

44

Issue

5

Start / End Page

1477 / 1479

Related Subject Headings

  • Treatment Outcome
  • Ticlopidine
  • Ticagrelor
  • Thrombosis
  • Stroke
  • Secondary Prevention
  • Purinergic P2Y Receptor Antagonists
  • Platelet Aggregation Inhibitors
  • Neurology & Neurosurgery
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
James, S. K., Pieper, K. S., Cannon, C. P., Storey, R. F., Becker, R. C., Steg, P. G., … PLATO study group, . (2013). Ticagrelor in patients with acute coronary syndromes and stroke: interpretation of subgroups in clinical trials. Stroke, 44(5), 1477–1479. https://doi.org/10.1161/strokeaha.111.000514
James, Stefan K., Karen S. Pieper, Christopher P. Cannon, Robert F. Storey, Richard C. Becker, Philippe Gabriel Steg, Lars Wallentin, Robert A. Harrington, and Robert A. PLATO study group. “Ticagrelor in patients with acute coronary syndromes and stroke: interpretation of subgroups in clinical trials.Stroke 44, no. 5 (May 2013): 1477–79. https://doi.org/10.1161/strokeaha.111.000514.
James SK, Pieper KS, Cannon CP, Storey RF, Becker RC, Steg PG, et al. Ticagrelor in patients with acute coronary syndromes and stroke: interpretation of subgroups in clinical trials. Stroke. 2013 May;44(5):1477–9.
James, Stefan K., et al. “Ticagrelor in patients with acute coronary syndromes and stroke: interpretation of subgroups in clinical trials.Stroke, vol. 44, no. 5, May 2013, pp. 1477–79. Epmc, doi:10.1161/strokeaha.111.000514.
James SK, Pieper KS, Cannon CP, Storey RF, Becker RC, Steg PG, Wallentin L, Harrington RA, PLATO study group. Ticagrelor in patients with acute coronary syndromes and stroke: interpretation of subgroups in clinical trials. Stroke. 2013 May;44(5):1477–1479.

Published In

Stroke

DOI

EISSN

1524-4628

ISSN

0039-2499

Publication Date

May 2013

Volume

44

Issue

5

Start / End Page

1477 / 1479

Related Subject Headings

  • Treatment Outcome
  • Ticlopidine
  • Ticagrelor
  • Thrombosis
  • Stroke
  • Secondary Prevention
  • Purinergic P2Y Receptor Antagonists
  • Platelet Aggregation Inhibitors
  • Neurology & Neurosurgery
  • Humans